FDA Investigator

Emily A Walters

Latest inspection on record: Doylestown, United States, May 2026 · records back to 2021

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 86 inspections across 83 sites are on record.
  • 111 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-13.

At a glance

Inspections

86

Sites

83

Observations

111

Career since

Aug 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Serologix, LLC13 May 2026Biologics
Central Pennsylvania Blood Bank24 Apr 2026BiologicsOn file
University of Pittsburg Medical Center, Hillman Cancer Center23 Apr 2026Biologics
Greater Delaware Valley Society of Transplant Surgeons22 Apr 2026Biologics
New York Blood Center Enterprises3 Apr 2026BiologicsOn file

Sites inspected

Serologix, LLCDoylestown, United States1 insp.
Central Pennsylvania Blood BankHershey, United States1 insp.
University of Pittsburg Medical Center, Hillman Cancer CenterCarlisle, United States1 insp.
Greater Delaware Valley Society of Transplant SurgeonsHershey, United States1 insp.
New York Blood Center EnterprisesRye, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Kish Bolden12 shared
Sarah M Forney4 shared
Irina Gaberman2 shared
Michele Gottshall2 shared
Jannet M Peroti2 shared
Christopher J Adams2 shared
Cara M Minelli2 shared
Jennifer L Diaz1 shared

Full investigator report

Get the verbatim findings behind Emily A Walters' 111 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators